{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:34:43Z","timestamp":1774614883304,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cgh.2014.10.032","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T11:45:04Z","timestamp":1415274304000},"page":"970-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Chung-Il","family":"Wi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Moynihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageswar R.","family":"Madde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl C.","family":"Grendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Ray","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2014.10.032_bib1","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.10.032_bib2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.22106","article-title":"A\u00a0revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial","volume":"47","author":"Hsu","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.10.032_bib3","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2014.10.032_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.10.032_bib5","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","article-title":"American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases","volume":"28","author":"Artz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2014.10.032_bib6","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.2011.35.1635","article-title":"Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors","volume":"29","author":"Day","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2014.10.032_bib7","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2011.40.7510","article-title":"Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis","volume":"30","author":"Zurawska","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2014.10.032_bib8","unstructured":"Hwang JP, Bardo A, Perrillo R. International survey on reactivation of hepatitis B induced by cancer chemotherapy (abstr). AASLD Emerg Trends Conf 2013;2013."},{"key":"10.1016\/j.cgh.2014.10.032_bib9","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1200\/JOP.2011.000450","article-title":"Low rates of hepatitis B virus screening at the onset of chemotherapy","volume":"8","author":"Hwang","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.cgh.2014.10.032_bib10","doi-asserted-by":"crossref","unstructured":"Artz AS, Somerfield MR, Feld JJ, et\u00a0al. Special announcement, 2013. ASCO Provisional Clinical Opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. Available: http:\/\/www.asco.org\/quality-guidelines\/asco-provisional-clinical-opinion-chronic-hepatitis-b-virus-infection-screening. J Clin Oncol 2010;28:3199\u20133202.","DOI":"10.1200\/JCO.2010.30.0673"},{"key":"10.1016\/j.cgh.2014.10.032_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2036.2009.04158.x","article-title":"Screening for hepatitis B in chemotherapy patients: survey of current oncology practices","volume":"31","author":"Tran","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2014.10.032_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000183731","article-title":"Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation","volume":"55","author":"Khokhar","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cgh.2014.10.032_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1200\/JOP.2010.000133","article-title":"Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists","volume":"7","author":"Day","year":"2011","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.cgh.2014.10.032_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1440-1746.2012.07280.x","article-title":"Hepatitis B virus reactivation associated with anti-neoplastic therapy","volume":"28","author":"Yeo","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2014.10.032_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.21024","article-title":"A\u00a0randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization","volume":"43","author":"Jang","year":"2006","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514015833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514015833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:16:00Z","timestamp":1761542160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356514015833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1542356514015833"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2014.10.032","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2014.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}